Mikhail Kashlev

Title: Mikhail Kashlev: Innovator in RNA Nanoparticle Technology

Introduction

Mikhail Kashlev is a prominent inventor based in Frederick, MD (US). He has made significant contributions to the field of RNA technology, particularly in the development of RNA nanoparticles. His innovative work has implications for various applications in medicine and biotechnology.

Latest Patents

Mikhail Kashlev holds a patent for the "Co-transcriptional assembly of modified RNA nanoparticles." This patent describes a method for generating RNA nanoparticles that incorporate modified nucleotides and exhibit increased resistance to nucleases. The RNA nanoparticles are formed cotranscriptionally by T7 RNA polymerase in the presence of manganese ions. This advancement represents a notable step forward in the field of RNA research.

Career Highlights

Throughout his career, Mikhail Kashlev has worked with esteemed organizations, including the National Institutes of Health, a component of the US Department of Health & Human Services, and the University of California. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Mikhail has collaborated with notable colleagues such as Bruce Allen Shapiro and Kirill Andreevich Afonin. These partnerships have further enriched his research and innovation in RNA technology.

Conclusion

Mikhail Kashlev's work in RNA nanoparticles showcases his dedication to advancing scientific knowledge and technology. His contributions have the potential to impact various fields, particularly in medicine and biotechnology.